EOS Imaging (Formerly Known as biospace med) Obtains Regulatory Authorization to Sell Its Products in Japan

Published: Oct 24, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(NYSE Euronext, FR0011191766-EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced that Japanese regulatory authorities have authorized the sale of EOS® and sterEOS®. EOS imaging’s medical imaging system, which is comprised of EOS® and sterEOS®, offers very low radiation dose 2D and 3D X-ray imaging of the full body in a natural weight-bearing position (standing or sitting). It has already been approved for sale in more than 30 countries.

Help employers find you! Check out all the jobs and post your resume.

Back to news